Curcumin against hepatitis C virus infection: Spicing up antiviral therapies with 'nutraceuticals'?

Gut

Volumn 63, Issue 7, 2014, Pages 1035-1037

  Pécheur, Eve Isabelle ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CURCUMIN; CYCLOSPORIN; NUTRACEUTICAL; RIBAVIRIN;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; DRUG SOLUBILITY; ENDEMIC DISEASE; ENDOCYTOSIS; GASTROINTESTINAL DISEASE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL; LIVER PROTECTION; NONHUMAN; NOTE; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RECURRENT INFECTION; SEROPREVALENCE; VIRUS ENTRY;

ANTIVIRAL THERAPY; CHRONIC VIRAL HEPATITIS; HCV; HEPATITIS C; LIVER TRANSPLANTATION;

ANIMALS; ANTIVIRAL AGENTS; CURCUMIN; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; VIRUS INTERNALIZATION;

EID: 84902256123     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-305646     Document Type: Note

References (11)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57: 1333-42.
2. Bartenschlager R, Penin F, Lohmann V, et al. Assembly of infectious hepatitis C virus particles. Trends Microbiol 2011;19:95-103.
3. Aghemo A, De Francesco R. New horizons in hepatitis C antiviral therapy with direct- Acting antivirals. Hepatology 2013;58:428-38.
4. Crespo G, Mariño Z, Navasa M, et al. Viral hepatitis in liver transplantation. Gastroenterology 2012;142:1373-83.
5. Blaising J, Lévy PL, Gondeau C, et al. Silibinin inhibits hepatitis C virus entry into hepatocytes by hindering clathrin-dependent trafficking. Cell Microbiol 2013. doi:10.1111/cmi.12155.
6. Ciesek S, von Hahn T, Colpitts CC, et al. The green tea polyphenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology 2011;54: 1947-55.
7. Haid S, Novodomska A, Gentzsch J, et al. A plant-derived flavonoid inhibits entry of all HCV genotypes into human hepatocytes. Gastroenterology 2012;143:213-22.
8. Esatbeyoglu T, Huebbe P, Ernst IMA, et al. Curcumin-From molecule to biological function. Angew Chem Int Ed 2012;51:5308-32.
9. Anggakusuma A, Colpitts CC, Schang LM, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Gut 2014;63: 1137-49.
10. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013;15:195-218.
11. Zeisel MB, Felmlee DJ, Baumert TF. Hepatitis C virus entry. Curr Top Microbiol Immunol 2013;369:87-112.